Autolus Competitors and Similar CompaniesClear all

Autolus's competitors and similar companies include Cellink and Aquinnah Pharmaceuticals.
Autolus
Autolus
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
Cellink
Cellink
CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
Aquinnah Pharmaceuticals
Aquinnah Pharmaceuticals
Aquinnah Pharmaceuticals is a company that specializes in developing drugs for neurodegenerative diseases.
Founding Date
Founding Date
2014
Founding Date
2016
Founding Date
2014
Type
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
London, GB HQ
London, GB
Locations
Göteborg, SE HQ
Dardilly, FR
Kyoto, JP
Göteborg, SE
Brighton, GB
Blacksburg, US
Boston, US
Locations
Cambridge, US HQ
Employees
Employees
647
Employees
851% decrease
Employees
17

Financial

Revenue (est.)
Revenue (est.)
$75.4m (FY, 2025)
Revenue (est.)
kr74.2m (FY, 2021)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$86.6m (FY, 2025)
Cost of goods
kr40.2m (FY, 2021)
Cost of goods
N/A
Gross profit
Gross profit
($10.7m) (FY, 2025)
Gross profit
kr34.1m (FY, 2021)
Gross profit
N/A
Net income
Net income
($287.5m) (FY, 2025)
Net income
(kr27.4m) (FY, 2021)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 281.7m
Total funding raised
$ 4.1m
Total funding raised
$ 19.8m
For sources of this data, please see the company profile

View Company Profiles

Cellink
HQ
Göteborg, SE

CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.

View company
Aquinnah Pharmaceuticals
HQ
Cambridge, US
Employees
17

Aquinnah Pharmaceuticals is a company that specializes in developing drugs for neurodegenerative diseases.

View company